Prevalence of Neisseria gonorrhoeae (NG) and of Chlamydia trachomatis (CT) infections according to demographic, behavioural, and clinical characteristics
| NG+/total | p Value | CT+/total | p Value | NG and/or CT+/total | p Value | |
|---|---|---|---|---|---|---|
| Country | ||||||
| Benin | 1/81 (1.2%) | 0.01 | 1/81 (1.2%) | 0.31 | 2/81 (2.5%) | 0.08 |
| Burkina Faso | 2/195 (1.0%) | 9/195 (4.6%) | 10/195 (5.1%) | |||
| Ghana | 0/199 (0%) | 3/199 (1.5%) | 3/199 (1.5%) | |||
| Guinea | 6/137 (4.4%) | 6/137 (4.4%) | 9/137 (6.6%) | |||
| Mali | 5/114 (4.4%) | 4/114 (3.5%) | 8/114 (7.0%) | |||
| Age (years) | ||||||
| 12–20 | 4/156 (2.6%) | 0.52 | 4/156 (2.6%) | 0.38 | 8/156 (5.1%) | 0.32 |
| 21–29 | 8/371 (2.2%) | 15/371 (4.0%) | 19/371 (5.1%) | |||
| 30 or more | 2/198 (1.0%) | 4/198 (2.0%) | 5/198 (2.5%) | |||
| Marital status | ||||||
| Never married | 4/291 (1.4%) | 0.40 | 9/291 (3.1%) | 0.84 | 11/291 (3.8%) | 0.20 |
| Currently married | 9/416 (2.2%) | 13/416 (3.1%) | 20/416 (4.8%) | |||
| Widowed/divorced | 1/18 (5.6%) | 1/18 (5.6%) | 1/18 (5.6%) | |||
| Education | ||||||
| None | 8/210 (3.8%) | 0.06 | 14/210 (6.7%) | 0.002 | 17/210 (8.1%) | 0.006 |
| Primary school | 3/204 (1.5%) | 3/204 (1.5%) | 6/204 (2.9%) | |||
| Secondary school or more | 3/304 (1.0%) | 5/304 (1.6%) | 8/304 (2.6%) | |||
| Number of sex partners, past 3 months | ||||||
| 0 | 0/92 (0%) | 0.25 | 0/92 (0%) | <0.001 | 0/92 (0%) | <0.001 |
| 1 | 13/581 (2.2%) | 18/581 (3.1%) | 26/581 (4.5%) | |||
| 2 or more | 0/31 (0%) | 5/31 (16.1%) | 5/31 (16.1%) | |||
| New sex partner in past 3 months | ||||||
| Yes | 2/121 (1.7%) | 1.00 | 6/121 (5.0%) | 0.25 | 7/121 (5.8%) | 0.57 |
| No | 12/604 (2.0%) | 17/604 (2.8%) | 25/604 (4.1%) | |||
| Urethral discharge in partner | ||||||
| Yes | 2/46 (4.3%) | 0.21 | 0/46 (0%) | 0.39 | 2/46 (4.3%) | 1.00 |
| No | 11/645 (1.7%) | 23/645 (3.6%) | 29/645 (4.5%) | |||
| Condom use by partner | ||||||
| Never | 12/494 (2.4%) | 0.12 | 17/494 (3.4%) | 0.88 | 25/494 (5.1%) | 0.43 |
| Sometimes | 0/152 (0%) | 4/152 (2.6%) | 4/152 (2.6%) | |||
| Always | 2/56 (3.6%) | 2/56 (3.6%) | 3/56 (5.4%) | |||
| Duration of discharge, days | ||||||
| 1–7 | 2/169 (1.2%) | 0.44 | 7/169 (4.1%) | 0.68 | 7/169 (4.1%) | 0.84 |
| 8–21 | 2/159 (1.3%) | 4/159 (2.5%) | 6/159 (3.8%) | |||
| >21 | 10/394 (2.5%) | 12/394 (3.0%) | 19/394 (4.8%) | |||
| Previous treatment | ||||||
| Yes | 7/242 (2.9%) | 0.25 | 7/242 (2.9%) | 0.92 | 11/242 (4.5%) | 0.93 |
| No | 7/479 (1.5%) | 16/479 (3.3%) | 21/479 (4.4%) | |||
| Dysuria | ||||||
| Yes | 7/169 (4.1%) | 0.03 | 7/169 (4.1%) | 0.57 | 11/169 (6.5%) | 0.10 |
| No | 7/556 (1.3%) | 16/556 (2.9%) | 21/556 (3.8%) | |||
| Dyspareunia | ||||||
| Yes | 7/224 (3.1%) | 0.14 | 13/224 (5.8%) | 0.01 | 16/224 (7.1%) | 0.03 |
| No | 7/501 (1.4%) | 10/501 (2.0%) | 16/501 (3.2%) | |||
| Cervical discharge | ||||||
| Yes | 10/369 (2.7%) | 0.20 | 16/369 (4.3%) | 0.11 | 21/369 (5.7%) | 0.13 |
| No | 4/354 (1.1%) | 7/354 (2.0%) | 11/354 (3.1%) | |||
| Pus on cervical swab | ||||||
| Yes | 3/82 (3.7%) | 0.22 | 6/82 (7.3%) | 0.04 | 8/82 (9.8%) | 0.02 |
| No | 11/624 (1.8%) | 17/624 (2.7%) | 24/624 (3.8%) | |||
| Inflammatory cervix | ||||||
| Yes | 7/187 (3.7%) | 0.06 | 9/187 (4.8%) | 0.25 | 12/187 (6.4%) | 0.22 |
| No | 7/519 (1.3%) | 14/519 (2.7%) | 20/519 (3.9%) | |||
| Bleeding after cervical sampling | ||||||
| Yes | 5/138 (3.6%) | 0.16 | 7/138 (5.1%) | 0.18 | 9/138 (6.5%) | 0.31 |
| No | 9/568 (1.6%) | 16/568 (2.8%) | 23/568 (4.0%) | |||
| Pelvic pain on examination | ||||||
| Yes | 4/60 (6.7%) | 0.02 | 2/60 (3.3%) | 1.00 | 4/60 (6.7%) | 0.33 |
| No | 10/653 (1.5%) | 21/653 (3.2%) | 28/653 (4.3%) | |||